CMS assigns Q codes to procedures, services, and supplies on a temporary basis. When a permanent code is assigned, the Q code is deleted and cross-referenced.

View All HCPCS Sections

• Q4437

  Revival ac, per square centimeter (add-on, list separately in addition to primary procedure)

• Q4438

  Pretect, per square centimeter (add-on, list separately in addition to primary procedure)

• Q4439

  Instagraft, per square centimeter (add-on, list separately in addition to primary procedure)

• Q4440

  Curamatrix, per square centimeter (add-on, list separately in addition to primary procedure)

• Q5001

  Hospice or home health care provided in patient's home/residence

• Q5002

  Hospice or home health care provided in assisted living facility

• Q5003

  Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf)

• Q5004

  Hospice care provided in skilled nursing facility (snf)

• Q5005

  Hospice care provided in inpatient hospital

• Q5006

  Hospice care provided in inpatient hospice facility

• Q5007

  Hospice care provided in long term care facility

• Q5008

  Hospice care provided in inpatient psychiatric facility

• Q5009

  Hospice or home health care provided in place not otherwise specified (nos)

• Q5010

  Hospice home care provided in a hospice facility

• Q5098

  Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg

• Q5099

  Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mg

• Q5100

  Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg

• Q5101

  Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram

• Q5102

  Injection, infliximab, biosimilar, 10 mg

• Q5103

  Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg

• Q5104

  Injection, infliximab-abda, biosimilar, (renflexis), 10 mg

• Q5105

  Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units

• Q5106

  Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units

• Q5107

  Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg

• Q5108

  Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg

• Q5109

  Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg

• Q5110

  Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram

• Q5111

  Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg

• Q5112

  Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg

• Q5113

  Injection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg

• Q5114

  Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg

• Q5115

  Injection, rituximab-abbs, biosimilar, (truxima), 10 mg

• Q5116

  Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg

• Q5117

  Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg

• Q5118

  Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg

• Q5119

  Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg

• Q5120

  Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg

• Q5121

  Injection, infliximab-axxq, biosimilar, (avsola), 10 mg

• Q5122

  Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg

• Q5123

  Injection, rituximab-arrx, biosimilar, (riabni), 10 mg

• Q5124

  Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg

• Q5125

  Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram

• Q5126

  Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg

• Q5127

  Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg

• Q5128

  Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg

• Q5129

  Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg

• Q5130

  Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg

• Q5131

  Injection, adalimumab-aacf (idacio), biosimilar, 20 mg

• Q5132

  Injection, adalimumab-afzb (abrilada), biosimilar, 10 mg

• Q5133

  Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/4/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.